• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小鼠肝细胞癌导致树突状细胞的功能损伤。

Functional impairment of dendritic cells caused by murine hepatocellular carcinoma.

作者信息

Lee Wei-Chen, Chiang Yang-Jen, Wang Hui-Chuan, Wang Min-Ru, Lia Shin-Ru, Chen Miin-Fu

机构信息

Laboratory of Immunology, Department of General Surgery, Chang-Gung Memorial Hospital, Taipei, Taiwan.

出版信息

J Clin Immunol. 2004 Mar;24(2):145-54. doi: 10.1023/B:JOCI.0000019779.56180.a2.

DOI:10.1023/B:JOCI.0000019779.56180.a2
PMID:15024181
Abstract

Immunosuppression in tumor-bearing hosts may be a major obstacle in eradicating tumors. This study investigated whether hepatocellular carcinoma suppressed the functions of dendritic cells to escape tumor surveillance. Dendritic cells (DC), propagated from C57BL/10J mice, were cocultured with or without murine hepatoma Hepa1-6 cells to examine the influence of hepatocellular carcinoma on dendritic cells. The results revealed that dendritic cells cocultured with hepatoma cells expressed low levels of costimulatory molecules, and the stimulatory capacity was decreased. The antigen-specific cytotoxic effects of T cells activated by the DC cocultured with hepatoma cells were also decreased. In ex vivo studies, the maturation and function of dendritic cells propagated from tumor-bearing mice were suppressed. The suppressive effect of Hepa1-6 cells on dendritic cells could be partially reversed by neutralizing IL-10. In conclusion, the maturation and stimulatory function of DC are suppressed by hepatocellular carcinoma. IL-10 release may be one of the mechanisms employed by hepatocellular carcinoma to suppress dendritic cells.

摘要

荷瘤宿主中的免疫抑制可能是根除肿瘤的主要障碍。本研究调查了肝细胞癌是否通过抑制树突状细胞的功能来逃避肿瘤监视。从C57BL/10J小鼠中培养的树突状细胞(DC)与鼠肝癌Hepa1-6细胞共培养或不共培养,以研究肝细胞癌对树突状细胞的影响。结果显示,与肝癌细胞共培养的树突状细胞共刺激分子表达水平较低,刺激能力下降。由与肝癌细胞共培养的DC激活的T细胞的抗原特异性细胞毒性作用也降低。在体外研究中,荷瘤小鼠来源的树突状细胞的成熟和功能受到抑制。中和IL-10可部分逆转Hepa1-6细胞对树突状细胞的抑制作用。总之,肝细胞癌抑制DC的成熟和刺激功能。IL-10释放可能是肝细胞癌抑制树突状细胞的机制之一。

相似文献

1
Functional impairment of dendritic cells caused by murine hepatocellular carcinoma.小鼠肝细胞癌导致树突状细胞的功能损伤。
J Clin Immunol. 2004 Mar;24(2):145-54. doi: 10.1023/B:JOCI.0000019779.56180.a2.
2
Antitumour activity mediated by CD4+ cytotoxic T lymphocytes against MHC class II-negative mouse hepatocellular carcinoma induced by dendritic cell vaccine and interleukin-12.树突状细胞疫苗和白细胞介素-12诱导的CD4+细胞毒性T淋巴细胞对MHC II类阴性小鼠肝细胞癌的抗肿瘤活性
Immunology. 2005 Aug;115(4):451-61. doi: 10.1111/j.1365-2567.2005.02179.x.
3
Inactivation of tumor-specific CD8⁺ CTLs by tumor-infiltrating tolerogenic dendritic cells.肿瘤浸润性耐受原性树突状细胞使肿瘤特异性 CD8⁺ CTL 失活。
Immunol Cell Biol. 2013 Oct;91(9):545-55. doi: 10.1038/icb.2013.38. Epub 2013 Sep 10.
4
Autoimmune hepatic inflammation by vaccination of mice with dendritic cells loaded with well-differentiated hepatocellular carcinoma cells and administration of interleukin-12.通过用负载有高分化肝癌细胞的树突状细胞对小鼠进行疫苗接种并给予白细胞介素-12诱导自身免疫性肝脏炎症。
Clin Immunol. 2005 Dec;117(3):280-93. doi: 10.1016/j.clim.2005.08.010. Epub 2005 Oct 24.
5
Up-regulated myeloid-derived suppressor cell contributes to hepatocellular carcinoma development by impairing dendritic cell function.上调的髓源性抑制细胞通过损害树突状细胞功能促进肝细胞癌的发展。
Scand J Gastroenterol. 2011 Feb;46(2):156-64. doi: 10.3109/00365521.2010.516450. Epub 2010 Sep 7.
6
Improvement of dendritic-based vaccine efficacy against hepatitis B virus-related hepatocellular carcinoma by two tumor-associated antigen gene-infected dendritic cells.通过感染两种肿瘤相关抗原基因的树突状细胞提高基于树突状细胞的乙型肝炎病毒相关肝细胞癌疫苗的疗效。
Hum Immunol. 2010 Mar;71(3):255-62. doi: 10.1016/j.humimm.2009.12.010. Epub 2010 Jan 8.
7
Tumor antigen pulsed dendritic cells enhance the cytolytic activity of tumor infiltrating lymphocytes in human hepatocellular cancer.肿瘤抗原脉冲树突状细胞增强人肝细胞癌中肿瘤浸润淋巴细胞的细胞溶解活性。
Cancer Biother Radiopharm. 2000 Oct;15(5):477-86. doi: 10.1089/cbr.2000.15.477.
8
[Changes in the immune function of dendritic cells (DC) derived from HBV-related hepatocellular carcinoma (HCC) patient's peripheral blood monocytes (PBMC) pulsed with tumor antigen].[用肿瘤抗原脉冲处理的乙肝相关肝细胞癌(HCC)患者外周血单核细胞(PBMC)来源的树突状细胞(DC)免疫功能的变化]
Zhonghua Gan Zang Bing Za Zhi. 2005 May;13(5):339-42.
9
Cognate interactions between memory T cells and tumor antigen-presenting dendritic cells from bone marrow of breast cancer patients: bidirectional cell stimulation, survival and antitumor activity in vivo.乳腺癌患者骨髓来源的记忆T细胞与肿瘤抗原呈递树突状细胞之间的同源相互作用:体内双向细胞刺激、存活及抗肿瘤活性
Int J Cancer. 2003 Jan 1;103(1):73-83. doi: 10.1002/ijc.10781.
10
Hepatoma cells inhibit the differentiation and maturation of dendritic cells and increase the production of regulatory T cells.肝癌细胞会抑制树突状细胞的分化和成熟,并增加调节性T细胞的产生。
Immunol Lett. 2007 Nov 30;114(1):38-45. doi: 10.1016/j.imlet.2007.09.003. Epub 2007 Oct 2.

引用本文的文献

1
Research Progress on Dendritic Cells in Hepatocellular Carcinoma Immune Microenvironments.肝细胞癌免疫微环境中树突状细胞的研究进展。
Biomolecules. 2024 Sep 16;14(9):1161. doi: 10.3390/biom14091161.
2
Serum cytokine levels in patients with chronic hepatitis B according to lamivudine therapy.根据拉米夫定治疗,慢性乙型肝炎患者的血清细胞因子水平。
J Clin Lab Anal. 2011 Nov;25(6):414-21. doi: 10.1002/jcla.20495.
3
Immunotherapeutic modulation of the suppressive liver and tumor microenvironments.免疫治疗调节抑制性肝和肿瘤微环境。

本文引用的文献

1
A novel technique for the fluorometric assessment of T lymphocyte antigen specific lysis.
J Immunol Methods. 2001 Mar 1;249(1-2):99-110. doi: 10.1016/s0022-1759(00)00329-x.
2
The role for transforming growth factor-beta (TGF-beta) in human cancer.转化生长因子-β(TGF-β)在人类癌症中的作用。
Crit Rev Oncog. 1999;10(4):303-60.
3
T cell-derived IL-10 promotes lung cancer growth by suppressing both T cell and APC function.T细胞来源的白细胞介素-10通过抑制T细胞和抗原呈递细胞的功能来促进肺癌生长。
Int Immunopharmacol. 2011 Jul;11(7):879-89. doi: 10.1016/j.intimp.2010.12.024. Epub 2011 Jan 15.
J Immunol. 1999 Nov 1;163(9):5020-8.
4
Signaling defects in T lymphocytes of patients with malignancy.恶性肿瘤患者T淋巴细胞中的信号缺陷。
Cancer Immunol Immunother. 1999 Oct;48(7):346-52. doi: 10.1007/s002620050585.
5
Interleukin-10: a cytokine used by tumors to escape immunosurveillance.白细胞介素-10:一种肿瘤用来逃避免疫监视的细胞因子。
Med Oncol. 1999 Jul;16(2):86-94. doi: 10.1007/BF02785841.
6
Effects of TGF-beta on the immune system: implications for cancer immunotherapy.转化生长因子-β对免疫系统的影响:对癌症免疫治疗的启示
Leukemia. 1999 Aug;13(8):1188-99. doi: 10.1038/sj.leu.2401477.
7
Impediments to successful immunotherapy.成功免疫治疗的障碍。
Pharmacol Ther. 1999 Feb;81(2):111-9. doi: 10.1016/s0163-7258(98)00038-2.
8
The Fas counterattack: cancer as a site of immune privilege.Fas反击:癌症作为免疫豁免部位
Immunol Today. 1999 Jan;20(1):46-52. doi: 10.1016/s0167-5699(98)01382-6.
9
Dendritic cells and the control of immunity.树突状细胞与免疫调控
Nature. 1998 Mar 19;392(6673):245-52. doi: 10.1038/32588.
10
Multidimensional flow-cytometric analysis of dendritic cells in peripheral blood of normal donors and cancer patients.正常供体和癌症患者外周血中树突状细胞的多参数流式细胞术分析
Cancer Immunol Immunother. 1998 Jan;45(5):234-40. doi: 10.1007/s002620050438.